A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Pierre-Antoine JugeBenjamin GrangerMarie-Pierre DebrayEsther EbsteinFabienne Louis-SidneyJoanna KedraTracy J DoyleRaphaël BorieArnaud ConstantinBernard CombeRené-Marc FlipoXavier MarietteOlivier VittecoqAlain SarauxGuillermo Carvajal-AlegriaJean SibiliaFrancis BerenbaumCaroline KannengiesserCatherine BoileauJeffrey A SparksBruno CrestaniBruno FautrelPhilippe Dieudé

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2022)

We developed and validated a risk score that could help identify patients at high risk of subclinical RA-ILD. Our findings support an important contribution of MUC5B rs35705950 to subclinical RA-ILD risk.

Keyphrases

interstitial lung disease
rheumatoid arthritis
systemic sclerosis
idiopathic pulmonary fibrosis
disease activity
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
ankylosing spondylitis
prognostic factors
peritoneal dialysis
systemic lupus erythematosus